Next Article in Journal
Serum and Sputum Eosinophil Cationic Protein Levels and Clinical Status in Cystic Fibrosis Patients
Previous Article in Journal
Gastroesophageal Reflux Disease (GERD) In Patients with Obstructive Sleep Apnoea Syndrome (OSAS)
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
ARM
Volume 74
Issue 4
10.5603/ARM.28017
arm-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles
Advances in Respiratory Medicine is published by MDPI from Volume 90 Issue 4 (2022). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Via Medica.
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Safety of Influenza Vaccination in Asthmatics

by
Tomasz Kmiecik
*,
Karolina Sęk
and
Paweł Górski
Klinika Pulmonologii i Alergologii Katedry Pneumonologii i Alergologii Uniwersytetu Medycznego w Łodzi, Łódź, Poland
*
Author to whom correspondence should be addressed.
Adv. Respir. Med. 2006, 74(4), 365-371; https://doi.org/10.5603/ARM.28017
Submission received: 4 August 2006 / Revised: 8 September 2006 / Accepted: 8 September 2006 / Published: 8 September 2006

Abstract

The common cause of exacerbations in asthmatics are viral infections. Infl uenza infection especially increases the risk of respiratory exacerbations. The ACIP report puts asthma among indications to regular infl uenza vaccinations. In practice, many physicians doubt in effectiveness and safety of vaccination in patients suffering from allergy. It caused such procedures were not included in asthma guidelines published by other authors. Our study confi rmed the safety of infl uenza split vaccine vaccination in asthmatics. We proved that vaccination had not any infl uence on asthma control in 14-day period after injection. We showed also high frequency of, mostly local, side effects. These events were generally mild and transient.
Keywords: asthma; allergy; infl uenza; vaccination; exacerbation asthma; allergy; infl uenza; vaccination; exacerbation

Share and Cite

MDPI and ACS Style

Kmiecik, T.; Sęk, K.; Górski, P. Safety of Influenza Vaccination in Asthmatics. Adv. Respir. Med. 2006, 74, 365-371. https://doi.org/10.5603/ARM.28017

AMA Style

Kmiecik T, Sęk K, Górski P. Safety of Influenza Vaccination in Asthmatics. Advances in Respiratory Medicine. 2006; 74(4):365-371. https://doi.org/10.5603/ARM.28017

Chicago/Turabian Style

Kmiecik, Tomasz, Karolina Sęk, and Paweł Górski. 2006. "Safety of Influenza Vaccination in Asthmatics" Advances in Respiratory Medicine 74, no. 4: 365-371. https://doi.org/10.5603/ARM.28017

APA Style

Kmiecik, T., Sęk, K., & Górski, P. (2006). Safety of Influenza Vaccination in Asthmatics. Advances in Respiratory Medicine, 74(4), 365-371. https://doi.org/10.5603/ARM.28017

Article Metrics

Back to TopTop